Norbert Schmitz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bernd Heinz-Wolfram; Ziepert Marita; Thorns Christoph; Klapper Wolfram; Wacker Hans-Heinrich; Hummel Michael; Stein Harald; Hansmann Martin-Leo; Ott German; Rosenwald Andreas; Müller-Hermelink Hans-Konrad; Barth Thomas F E; Möller Peter; Cogliatti Sergio B; Pfreundschuh Michael; Schmitz Norbert; Trümper Lorenz; Höller Silvia; Löffler Markus; Feller Alfred C;
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.
Claviez Alexander; Canals Carme; Dierickx Daan; Stein Jerry; Badell Isabel; Pession Andrea; Mackinnon Stephen; Slavin Shimon; Dalle Jean-Hugues; Chacón Manuel Jurado; Sarhan Mahmoud; Wynn Robert Francis; Suttorp Meinolf; Dini Giorgio; Sureda Anna; Schmitz Norbert;
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation.
Kyriakou Charalampia; Canals Carmen; Finke Jürgen; Kobbe Guido; Harousseau Jean-Luc; Kolb Hans-Jochem; Novitzky Nicolas; Goldstone Anthony H; Sureda Anna; Schmitz Norbert
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Norbert Schmitz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bernd Heinz-Wolfram; Ziepert Marita; Thorns Christoph; Klapper Wolfram; Wacker Hans-Heinrich; Hummel Michael; Stein Harald; Hansmann Martin-Leo; Ott German; Rosenwald Andreas; Müller-Hermelink Hans-Konrad; Barth Thomas F E; Möller Peter; Cogliatti Sergio B; Pfreundschuh Michael; Schmitz Norbert; Trümper Lorenz; Höller Silvia; Löffler Markus; Feller Alfred C;
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.
Haematologica 2009;94(11):1569-80.
2009: Claviez Alexander; Canals Carme; Dierickx Daan; Stein Jerry; Badell Isabel; Pession Andrea; Mackinnon Stephen; Slavin Shimon; Dalle Jean-Hugues; Chacón Manuel Jurado; Sarhan Mahmoud; Wynn Robert Francis; Suttorp Meinolf; Dini Giorgio; Sureda Anna; Schmitz Norbert;
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation.
Blood 2009;114(10):2060-7.
2009: Kyriakou Charalampia; Canals Carmen; Finke Jürgen; Kobbe Guido; Harousseau Jean-Luc; Kolb Hans-Jochem; Novitzky Nicolas; Goldstone Anthony H; Sureda Anna; Schmitz Norbert
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3951-8.
2009: Kornacker M; Stumm J; Pott C; Dietrich S; Süssmilch S; Hensel M; Nickelsen M; Witzens-Harig M; Kneba M; Schmitz N; Ho A D; Dreger P
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):722-8.
2009: Boehme Volkmar; Schmitz Norbert; Zeynalova Samira; Loeffler Markus; Pfreundschuh Michael
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Blood 2009;113(17):3896-902.
2008: Schetelig Johannes; van Biezen Anja; Brand Ronald; Caballero Dolores; Martino Rodrigo; Itala Maija; García-Marco José A; Volin Liisa; Schmitz Norbert; Schwerdtfeger Rainer; Ganser Arnold; Onida Francesco; Mohr Brigitte; Stilgenbauer Stephan; Bornhäuser Martin; de Witte Theo; Dreger Peter
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5094-100.
2008: Haase Matthias; Frommer Jörg; Franke Gabriele-Helga; Hoffmann Thilo; Schulze-Muetzel Jörg; Jäger Susanne; Grabe Hans-Jörgen; Spitzer Carsten; Schmitz Norbert
From symptom relief to interpersonal change: Treatment outcome and effectiveness in inpatient psychotherapy.
Psychotherapy research : journal of the Society for Psychotherapy Research 2008;18(5):615-24.
2008: Schmitz N
Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 5():v63-7.
2008: Ritgen M; Böttcher S; Stilgenbauer S; Bunjes D; Schubert J; Cohen S; Humpe A; Hallek M; Kneba M; Schmitz N; Döhner H; Dreger P;
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(7):1377-86.
2008: Friedrichs Birte; Siegel Sandra; Kloess Marita; Barsoum Adel; Coggin Joseph; Rohrer James; Jakob Ilja; Tiemann Markus; Heidorn Klaus; Schulte Christoph; Kabelitz Dieter; Steinmann Jörg; Schmitz Norbert; Zeis Matthias
Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(9):6374-84.
2008: Basecke Jorg; Podleschny Martina; Becker Annegret; Seiffert Edda; Schwiers Ivonne; Schwiers Roman; Haase Detlef; Glass Bertram; Schmitz Norbert; Trumper Lorenz; Griesinger Frank
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
British journal of haematology 2008;141(1):52-9.
2008: Duarte R F; Schmitz N; Servitje O; Sureda A
Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.
Bone marrow transplantation 2008;41(7):597-604.
2008: Russell Nigel; Mesters Rolf; Schubert Joerg; Boogaerts Marc; Johnsen Hans E; Canizo Consuelo Del; Baker Nigel; Barker Philippa; Skacel Tomas; Schmitz Norbert
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Haematologica 2008;93(3):405-12.
2008: Pfreundschuh M; Zwick C; Zeynalova S; Dührsen U; Pflüger K-H; Vrieling T; Mesters R; Mergenthaler H-G; Einsele H; Bentz M; Lengfelder E; Trümper L; Rübe C; Schmitz N; Loeffler M;
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):545-52.
2008: Pfreundschuh Michael; Schubert Joerg; Ziepert Marita; Schmits Rudolf; Mohren Martin; Lengfelder Eva; Reiser Marcel; Nickenig Christina; Clemens Michael; Peter Norma; Bokemeyer Carsten; Eimermacher Hartmut; Ho Anthony; Hoffmann Martin; Mertelsmann Roland; Trümper Lorenz; Balleisen Leopold; Liersch Ruediger; Metzner Bernd; Hartmann Frank; Glass Bertram; Poeschel Viola; Schmitz Norbert; Ruebe Christian; Feller Alfred C; Loeffler Markus;
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
The lancet oncology 2008;9(2):105-16.
2008: Kyriakou Charalampia; Canals Carmen; Goldstone Anthony; Caballero Dolores; Metzner Bernd; Kobbe Guido; Kolb Hans-Jochem; Kienast Joachim; Reimer Peter; Finke Jurgen; Oberg Gunnar; Hunter Ann; Theorin Niklas; Sureda Anna; Schmitz Norbert;
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):218-24.
2008: Sureda Anna; Robinson Stephen; Canals Carmen; Carella Angelo M; Boogaerts Marc A; Caballero Dolores; Hunter Ann E; Kanz Lothar; Slavin Shimon; Cornelissen Jan J; Gramatzki Martin; Niederwieser Dietger; Russell Nigel H; Schmitz Norbert
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):455-62.
2007: Schmitz Norbert; Dreger Peter; Glass Bertram; Sureda Anna
Allogeneic transplantation in lymphoma: current status.
Haematologica 2007;92(11):1533-48.
2007: Montoto S; Canals C; Rohatiner A Z S; Taghipour G; Sureda A; Schmitz N; Gisselbrecht C; Fouillard L; Milpied N; Haioun C; Slavin S; Conde E; Fruchart C; Ferrant A; Leblond V; Tilly H; Lister T A; Goldstone A H;
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(11):2324-31.
2007: Schmitz Norbert; Buske Christian; Gisselbrecht Christian
Autologous stem cell transplantation in lymphoma.
Seminars in hematology 2007;44(4):234-45.
2007: Metzgeroth G; Walz C; Score J; Siebert R; Schnittger S; Haferlach C; Popp H; Haferlach T; Erben P; Mix J; Müller M C; Beneke H; Müller L; Del Valle F; Aulitzky W E; Wittkowsky G; Schmitz N; Schulte C; Müller-Hermelink K; Hodges E; Whittaker S J; Diecker F; Döhner H; Schuld P; Hehlmann R; Hochhaus A; Cross N C P; Reiter A
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(6):1183-8.
2007: Dreger Peter; Schmitz Norbert
Autologous stem cell transplantation as part of first-line treatment of Waldenström's macroglobulinemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):623-4.
2007: Dreger Peter; Rieger Michael; Seyfarth Bärbel; Hensel Manfred; Kneba Michael; Ho Anthony D; Schmitz Norbert; Pott Christiane
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome.
Haematologica 2007;92(1):42-9.
2007: Boehme V; Zeynalova S; Kloess M; Loeffler M; Kaiser U; Pfreundschuh M; Schmitz N;
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):149-57.
2006: Schmitz Norbert; Eapen Mary; Horowitz Mary M; Zhang Mei-Jie; Klein John P; Rizzo J Douglas; Loberiza Fausto R; Gratwohl Alois; Champlin Richard E;
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Blood 2006;108(13):4288-90.
2006: Friedrichs Birte; Tiemann Markus; Salwender Hans; Verpoort Karl; Wenger Michael K; Schmitz Norbert
The effects of rituximab treatment during pregnancy on a neonate.
Haematologica 2006;91(10):1426-7.
2006: Friedrichs Birte; Siegel Sandra; Andersen Mads Hald; Schmitz Norbert; Zeis Matthias
Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies.
Leukemia & lymphoma 2006;47(6):978-85.
2006: Siegel Sandra; Wagner Andreas; Friedrichs Birte; Wendeler Anneke; Wendel Lena; Kabelitz Dieter; Steinmann Jörg; Barsoum Adel; Coggin Joseph; Rohrer James; Dreger Peter; Schmitz Norbert; Zeis Matthias
Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(11):6935-44.
2006: Engert Andreas; Bredenfeld Henning; Döhner Hartmut; Ho Anthony D; Schmitz Norbert; Berger Dietmar; Bacon Pamela; Skacel Tomas; Easton Valerie; Diehl Volker
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
Haematologica 2006;91(4):546-9.
2006: Seyfarth Bärbel; Josting Andreas; Dreyling Martin; Schmitz Norbert
Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease.
British journal of haematology 2006;133(1):3-18.
2006: Glass Bertram; Kloess Marita; Bentz Martin; Schlimok Günter; Berdel Wolfgang E; Feller Alfred; Trümper Lorenz; Loeffler Markus; Pfreundschuh Michael; Schmitz Norbert;
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma.
Blood 2006;107(8):3058-64.
2006: Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2006;37(5):439-49.
2006: Hoffmann Christian; Repp R; Schoch R; Gahn B; Schub N; Beck C; Humpe A; Kneba M; Horst H-A; Schmitz N; Gramatzki M
Successful autologous stem cell transplantation in a severely immunocompromised patient with relapsed AIDS-related B-cell lymphoma.
European journal of medical research 2006;11(2):73-6.
2006: Schmitz Nobert; Kloess Marita; Reiser Marcel; Berdel Wolfgang E; Metzner Bernd; Dorken Bernd; Kneba Michael; Trumper Lorenz; Loeffler Markus; Pfreundschuh Michael; Glass Bertram;
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Cancer 2006;106(1):136-45.
2005: Hiddemann Wolfgang; Kneba Michael; Dreyling Martin; Schmitz Norbert; Lengfelder Eva; Schmits Rudolf; Reiser Marcel; Metzner Bernd; Harder Harriet; Hegewisch-Becker Susanna; Fischer Thomas; Kropff Martin; Reis Hans-Edgar; Freund Mathias; Wörmann Bernhard; Fuchs Roland; Planker Manfred; Schimke Jörg; Eimermacher Hartmut; Trümper Lorenz; Aldaoud Ali; Parwaresch Reza; Unterhalt Michael
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood 2005;106(12):3725-32.
2005: Dreger P; Ritgen M; Böttcher S; Schmitz N; Kneba M
The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1135-8.
2005: Schmitz N; Sureda A
The role of allogeneic stem-cell transplantation in Hodgkin's disease.
European journal of haematology. Supplementum 2005;(66):146-9.
2005: Hertenstein Bernd; Hambach Lothar; Bacigalupo Andrea; Schmitz Norbert; McCann Shaun; Slavin Shimon; Gratwohl Alois; Ferrant Augustin; Elmaagacli Ahmet; Schwertfeger Rainer; Locasciulli Anna; Zander Axel; Bornhäuser Martin; Niederwieser Dietger; Ruutu Tapani;
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Haematologica 2005;90(7):969-75.
2005: Schmitz Norbert
Does hematopoietic stem cell transplantation improve patient outcome in juvenile myelomonocytic leukemia?
Nature clinical practice. Oncology 2005;2(6):294-5.
2005: Schmitz Norbert; Beksac Meral; Bacigalupo Andrea; Ruutu Tapani; Nagler Arnon; Gluckman Eliane; Russell Nigel; Apperley Jane; Szerm Jeff; Bradstock Kenneth; Buzyn Agnes; Schlegelberger Brigitte; Matcham James; Gratwohl Alois
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Haematologica 2005;90(5):643-8.
2005: Sonnen Ruth; Schmidt Wolf-Peter; Müller-Hermelink Hans Konrad; Schmitz Norbert
The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas.
British journal of haematology 2005;129(3):366-72.
2005: Schmits Rudolf; Schmitz Norbert; Pfreundschuh Michael;
The best treatment for diffuse large B-cell lymphoma: a German perspective.
Oncology (Williston Park, N.Y.) 2005;19(4 Suppl 1):16-25.
2005: Schmitz Norbert
The role of thrombopoetin in growing hematopoietic stem cells.
Haematologica 2005;90(2):145.
2005: Schmitz Norbert
Cytotoxic drugs, collection of stem cells and hematologic recovery after autologous transplantation.
Haematologica 2005;90(1):4-5.
2005: Ruutu T; Corradini P; Gratwohl A; Holler E; Apperley J; Dini G; Rocha V; Schmitz N; Socié G; Niederwieser D
Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 2005;35(2):121-4.
2004: Schmitz N; Ljungman P; Cordonnier C; Kempf C; Linkesch W; Alegre A; Solano C; Simonsson B; Sonnen R; Diehl V; Fischer T; Caballero D; Littlewood T; Noppeney R; Schafhausen P; Jost L; Delabarre F; Marcus R
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
Bone marrow transplantation 2004;34(11):955-62.
2004: Siegel S; Steinmann J; Schmitz N; Stuhlmann R; Dreger P; Zeis M
Identification of a survivin-derived peptide that induces HLA-A*0201-restricted antileukemia cytotoxic T lymphocytes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(12):2046-7.
2004: Lenz Georg; Dreyling Martin; Schiegnitz Eva; Forstpointner Roswitha; Wandt Hannes; Freund Mathias; Hess Georg; Truemper Lorenz; Diehl Volker; Kropff Martin; Kneba Michael; Schmitz Norbert; Metzner Bernd; Pfirrmann Markus; Unterhalt Michael; Hiddemann Wolfgang;
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.
Blood 2004;104(9):2667-74.
2004: Ritgen Matthias; Stilgenbauer Stephan; von Neuhoff Nils; Humpe Andreas; Brüggemann Monika; Pott Christiane; Raff Thorsten; Kröber Alexander; Bunjes Donald; Schlenk Richard; Schmitz Norbert; Döhner Hartmut; Kneba Michael; Dreger Peter
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.
Blood 2004;104(8):2600-2.
2004: Glass B; Nickelsen M; Dreger P; Claviez A; Hasenkamp J; Wulf G; Trümper L; Schmitz N
Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect.
Bone marrow transplantation 2004;34(5):391-7.
2004: Schmidt Wolf-Peter; Schmitz Norbert; Sonnen Ruth
Conservative management of gastric lymphoma: the treatment option of choice.
Leukemia & lymphoma 2004;45(9):1847-52.
2004: Pfreundschuh Michael; Trümper Lorenz; Kloess Marita; Schmits Rudolf; Feller Alfred C; Rübe Christian; Rudolph Christian; Reiser Marcel; Hossfeld Dieter K; Eimermacher Hartmut; Hasenclever Dirk; Schmitz Norbert; Loeffler Markus;
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
Blood 2004;104(3):634-41.
2004: Pfreundschuh Michael; Trümper Lorenz; Kloess Marita; Schmits Rudolf; Feller Alfred C; Rudolph Christian; Reiser Marcel; Hossfeld Dieter K; Metzner Bernd; Hasenclever Dirk; Schmitz Norbert; Glass Bertram; Rübe Christian; Loeffler Markus;
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.
Blood 2004;104(3):626-33.
2004: Hudis Clifford A; Schmitz Norbert
Dose-dense chemotherapy in breast cancer and lymphoma.
Seminars in oncology 2004;31(3 Suppl 8):19-26.
2004: Dreger Peter; Stilgenbauer Stephan; Benner Axel; Ritgen Matthias; Kröber Alexander; Kneba Michael; Schmitz Norbert; Döhner Hartmut
The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status.
Blood 2004;103(7):2850-8.
2004: Claviez Alexander; Klingebiel Thomas; Beyer Jörg; Nürnberger Wenzel; Ehninger Gerhard; Suttorp Meinolf; Dreger Peter; Dörffel Wolfgang; Schmitz Norbert
Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease.
Annals of hematology 2004;83(4):237-41.
2004: Schmitz Norbert; Sureda Anna; Robinson Stephen
Allogeneic transplantation of hematopoietic stem cells after nonmyeloablative conditioning for Hodgkin's disease: indications and results.
Seminars in oncology 2004;31(1):27-32.
2004: Weiss B; Hoffmann M; Anders C; Hellstern P; Schmitz N; Uppenkamp M;
Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers.
Annals of hematology 2004;83(1):44-9.
2004: Reimer Peter; Schertlin Tobias; Rüdiger Thomas; Geissinger Eva; Roth Sabine; Kunzmann Volker; Weissinger Florian; Nerl Christoph; Schmitz Norbert; Müller-Hermelink Hans Konrad; Wilhelm Martin
Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(4):304-11.
2003: Siegel Sandra; Wagner Andreas; Kabelitz Dieter; Marget Matthias; Coggin Joseph; Barsoum Adel; Rohrer James; Schmitz Norbert; Zeis Matthias
Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Blood 2003;102(13):4416-23.
2003: Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
Differences between graft product and donor side effects following bone marrow or stem cell donation.
Bone marrow transplantation 2003;32(9):873-80.
2003: Bierman Philip J; Sweetenham John W; Loberiza Fausto R; Taghipour Goli; Lazarus Hillard M; Rizzo J Douglas; Schmitz Norbert; van Besien Koen; Vose Julie M; Horowitz Mary; Goldstone Anthony;
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3744-53.
2003: Siegel Sandra; Wagner Andreas; Schmitz Norbert; Zeis Matthias
Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model.
British journal of haematology 2003;122(6):911-4.
2003: Platzbecker U; Ehninger G; Schmitz N; Bornhäuser M
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases.
Annals of hematology 2003;82(8):463-8.
2003: Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Bone marrow transplantation 2003;32(1):49-56.
2003: Kröger Nicolaus; Einsele Hermann; Wolff Daniel; Casper Jochen; Freund Mathias; Derigs Günter; Wandt Hannes; Schäfer-Eckart K; Wittkowsky Georg; Schmitz Norbert; Krüger William; Zabelina Tatjana; Renges Helmut; Ayuk Francis; Krüll Andreas; Zander Axel;
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).
Bone marrow transplantation 2003;31(11):973-9.
2003: Zeis Matthias; Siegel Sandra; Wagner Andreas; Schmitz Marc; Marget Matthias; Kühl-Burmeister Rita; Adamzik Ilse; Kabelitz Dieter; Dreger Peter; Schmitz Norbert; Heiser Axel
Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(11):5391-7.
2003: Gratwohl A; Baldomero H; Passweg J; Frassoni F; Niederwieser D; Schmitz N; Urbano-Ispizua A;
Hematopoietic stem cell transplantation for hematological malignancies in Europe.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(5):941-59.
2003: Peniket A J; Ruiz de Elvira M C; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone A H;
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Bone marrow transplantation 2003;31(8):667-78.
2003: Vandenberghe Elisabeth; Ruiz de Elvira Carmen; Loberiza Fausto R; Conde E; López-Guillermo A; Gisselbrecht C; Guilhot F; Vose Julie M; van Biesen Koen; Rizzo J Douglas; Weisenburger Dennis D; Isaacson Peter; Horowitz Mary M; Goldstone Anthony H; Lazarus Hillard M; Schmitz Norbert
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries.
British journal of haematology 2003;120(5):793-800.
2003: Sureda A; Schmitz N
Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies.
Annals of hematology 2003;82(1):1-13.
2003: Stritzke Jan; Zunkel Tim; Steinmann Jörg; Schmitz Norbert; Uharek Lutz; Zeis Matthias
Therapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma model.
British journal of haematology 2003;120(1):27-35.
2002: Sonnen Ruth; Schmidt Wolf-Peter; Kuse Rolf; Schmitz Norbert
Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity.
British journal of haematology 2002;119(3):634-9.
2002: Robinson Stephen P; Goldstone Anthony H; Mackinnon Stephen; Carella Angelo; Russell Nigel; de Elvira Carmen Ruiz; Taghipour Goli; Schmitz Norbert;
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.
Blood 2002;100(13):4310-6.
2002: Kröger Nicolaus; Sayer Herbert Gottfried; Schwerdtfeger Rainer; Kiehl Michael; Nagler Arnon; Renges Helmut; Zabelina Tatjana; Fehse Boris; Ayuk Francis; Wittkowsky Georg; Schmitz Norbert; Zander Axel Rolf
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
Blood 2002;100(12):3919-24.
2002: Kaiser Ulrich; Uebelacker Irmgard; Abel Ulrich; Birkmann Josef; Trümper Lorenz; Schmalenberg Harald; Karakas Tunca; Metzner Bernd; Hossfeld Dieter K; Bischoff Helge G; Franke Astrid; Reiser Marcel; Müller Peter; Mantovani Luisa; Grundeis Marc; Rothmann Frank; von Seydewitz Cay-Uwe; Mesters Rolf M; Steinhauer Ernst U; Krahl Dorothea; Schumacher Kurt; Kneba Michael; Baudis Michael; Schmitz Norbert; Pfab Rüdiger; Köppler Hubert; Parwaresch Reza; Pfreundschuh Michael; Havemann Klaus
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4413-9.
2002: Schmitz Norbert; Beksac Meral; Hasenclever Dirk; Bacigalupo Andrea; Ruutu Tapani; Nagler Arnon; Gluckman Eliane; Russell Nigel; Apperley Jane F; Gorin Norbert C; Szer Jeff; Bradstock Ken; Buzyn Agnes; Clark Peter; Borkett Keith; Gratwohl Alois;
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.
Blood 2002;100(3):761-7.
2002: Schmitz Norbert; Pfistner Beate; Sextro Michael; Sieber Markus; Carella Angelo M; Haenel Matthias; Boissevain Friederike; Zschaber Reinhart; Müller Peter; Kirchner Hartmut; Lohri Andreas; Decker Susanne; Koch Bettina; Hasenclever Dirk; Goldstone Anthony H; Diehl Volker;
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.
Lancet 2002;359(9323):2065-71.
2002: Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A;
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2002;29(8):639-46.
2002: Zeis Matthias; Zunkel Tim; Steinmann Jörg; Schmitz Norbert; Uharek Lutz
Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma.
British journal of haematology 2002;117(1):93-102.
2002: Kottaridis P D; Peggs K; Schmitz N; Dreger P; Boogaerts M A; Ferrant A; Demuynck H M; Zander A; Link H; Matcham J; Linch D C; Borkett K; Goldstone A H
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.
Leukemia & lymphoma 2002;43(3):531-6.
2002: Champlin R; Hesdorffer C; Lowenberg B; Martelli M F; Mertelsmann R H; Reisner Y; Schmitz N
Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(3):427-8.
2002: Zeis M; Frenzke H; Schmitz N; Uharek L; Steinmann J
Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
Bone marrow transplantation 2002;29(3):213-21.
2002: Schmitz Norbert; Barrett John
Optimizing engraftment--source and dose of stem cells.
Seminars in hematology 2002;39(1):3-14.
2002: Sureda A; Schmitz N
Role of allogeneic stem cell transplantation in relapsed or refractory Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():128-32.
2001: Ottinger H D; Müller C R; Goldmann S F; Albert E; Arnold R; Beelen D W; Blasczyk R; Bunjes D; Casper J; Ebell W; Ehninger G; Eiermann T; Einsele H; Fauser A; Ferencik S; Finke J; Hertenstein B; Heyll A; Klingebiel T; Knipper A; Kremens B; Kolb H J; Kolbe K; Lenartz E; Lindemann M; Müller C A; Mytilineos J; Niederwieser D; Runde V; Sayer H; Schaefer U W; Schmitz N; Schröder S; Schulze-Rath R; Schwerdtfeger R; Siegert W; Thiele B; Zander A R; Grosse-Wilde H
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.
Annals of hematology 2001;80(12):706-14.
2001: Seyfarth B; Kuse R; Sonnen R; Glass B; Schmitz N; Dreger P
Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?
Annals of hematology 2001;80(7):398-405.
2001: Schmitz N
Rituximab in autologous stem cell transplantation for follicular lymphoma.
Anti-cancer drugs 2001;12 Suppl 2():S21-4.
2001: Sweetenham J W; Santini G; Qian W; Guelfi M; Schmitz N; Simnett S; Nagler A; Holte H; Kvaloy S; Bruzzi P; Goldstone A H
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2927-36.
2001: Pfreundschuh M; Hasenclever D; Loeffler M; Ehninger G; Schmitz N; Kirchner H; Koch P; Lathan B; Rueffer U; Sextro M; Franklin J; Tesch H; Diehl V;
Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):471-7.
2001: Anderlini P; Rizzo J D; Nugent M L; Schmitz N; Champlin R E; Horowitz M M;
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases.
Bone marrow transplantation 2001;27(7):689-92.
2001: Dreger P; Schmitz N
Allogeneic transplantation of blood stem cells: coming of age?
Annals of hematology 2001;80(3):127-36.
2001: Zeis M; Steinmann J; Petrela E; Hartung G; Schmitz N; Uharek L
Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
Bone marrow transplantation 2001;27(3):279-85.
2001: Williams C D; Harrison C N; Lister T A; Norton A J; Blystad A K; Coiffier B; Taghipour G; Schmitz N; Goldstone A H;
High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):727-35.
2001: Schmitz N
6. Report on workshop: EBMT workshop "High dose therapy in aggressive NHL".
Annals of hematology 2001;80 Suppl 3():B24-5.
2001: Zeis M; Uharek L; Hartung G; Glass B; Steinmann J; Schmitz N
Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(2):136-44.
2000: Dreger P; Glass B; Seyfarth B; Humpe A; Claviez A; von Neuhoff N; Suttorp M; Schoch R; Schmitz N
Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT.
Bone marrow transplantation 2000;26(12):1361-2.
2000: Ringdén O; Labopin M; Gorin N C; Schmitz N; Schaefer U W; Prentice H G; Bergmann L; Jouet J P; Mandelli F; Blaise D; Fouillard L; Frassoni F;
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
British journal of haematology 2000;111(4):1130-7.
2000: Dreger P; Viehmann K; von Neuhoff N; Krüss D; Glass B; Kneba M; Mitsky P; Jopp P; Rautenberg P; Mills B; Schmitz N
A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia.
Experimental hematology 2000;28(10):1187-96.
2000: Ottinger H D; Müller C; Schmitz N; Kubanek B; Arnold R; Ebell W; Eberhard H P; Ehninger G; Fronz U; Goldmann S; Grosse-Wilde H; Havers W; Klingebiel T; Kolb H J; Seeber S; Schaefer U W; Baldomero H; Gratwohl A
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation.
Annals of hematology 2000;79(8):437-43.
2000: Dreger P; Rautenberg P; Kneba M; Schmitz N
Hepatitis B viremia in a patient with documented previous HBV immunity after autologous transplantation of highly purified PBSC.
Bone marrow transplantation 2000;26(1):114-6.
2000: Lehmann C; Zeis M; Schmitz N; Uharek L
Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.
Blood 2000;96(2):594-600.
2000: Champlin R E; Schmitz N; Horowitz M M; Chapuis B; Chopra R; Cornelissen J J; Gale R P; Goldman J M; Loberiza F R; Hertenstein B; Klein J P; Montserrat E; Zhang M J; Ringdén O; Tomany S C; Rowlings P A; Van Hoef M E; Gratwohl A
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
Blood 2000;95(12):3702-9.
2000: Dreger P; Martin S; Kuse R; Sonnen R; Glass B; Kröger N; Parwaresch R; Kneba M; Schmitz N; Haas R
The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):87-94.
2000: Dreger P; Michallet M; Schmitz N
Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():49-53.
1999: Sweetenham J W; Carella A M; Taghipour G; Cunningham D; Marcus R; Della Volpe A; Linch D C; Schmitz N; Goldstone A H
High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3101-9.
1999: Milligan D W; Ruiz De Elvira M C; Kolb H J; Goldstone A H; Meloni G; Rohatiner A Z; Colombat P; Schmitz N
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation.
British journal of haematology 1999;106(4):1020-6.
1999: Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
Bone marrow transplantation 1999;24(2):153-61.
1999: Dreger P; Glass B; Kuse R; Sonnen R; von Neuhoff N; Bolouri H; Kneba M; Schmitz N
Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenström's macroglobulinaemia.
British journal of haematology 1999;106(1):115-8.
1999: Lehmann C; Glass B; Zeis M; Schmitz N; Uharek L
Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity.
Cancer immunology, immunotherapy : CII 1999;48(4):209-13.
1999: Diehl V; Walshe R; Schmitz N
A new approach to safeguard high standards and cost containment of stem cell transplantation in Germany.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):609.
1999: Dreger P; Schmitz N
Allogeneic transplantation of peripheral blood stem cells.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):261-78.
1999: Shipp M A; Abeloff M D; Antman K H; Carroll G; Hagenbeek A; Loeffler M; Montserrat E; Radford J A; Salles G; Schmitz N; Symann M; Armitage J O; Philip T; Coiffier B
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):423-9.
1999: Shipp M A; Abeloff M D; Antman K H; Carroll G; Hagenbeek A; Loeffler M; Montserrat E; Radford J A; Salles G; Schmitz N; Symann M; Armitage J O; Coiffier B; Philip T
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):13-9.
1998: Russell N H; Gratwohl A; Schmitz N
Developments in allogeneic peripheral blood progenitor cell transplantation.
British journal of haematology 1998;103(3):594-600.
1998: Tesch H; Diehl V; Lathan B; Hasenclever D; Sieber M; Rüffer U; Engert A; Franklin J; Pfreundschuh M; Schalk K P; Schwieder G; Wulf G; Dölken G; Worst P; Koch P; Schmitz N; Bruntsch U; Tirier C; Müller U; Loeffler M
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
Blood 1998;92(12):4560-7.
1998: Harten P; Seyfarth B; Schmitz N
[Febrile neutropenia: practical aspects]
Medizinische Klinik (Munich, Germany : 1983) 1998;93(10):598-611.
1998: Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
Experimental hematology 1998;26(11):1068-73.
1998: von Neuhoff N; Dreger P; Suttorp M; Marget M; Kell S; Schmitz N
Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma.
Bone marrow transplantation 1998;22(2):161-6.
1998: Hartung G; Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Krönke M; Schmitz N
Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone.
Bone marrow transplantation 1998;21 Suppl 3():S16-20.
1998: Glass B; Uharek L; Hartung G; Zeis M; Steinmann J; Dreger P; Krönke M; Schmitz N
Immunotherapeutic aspects of allogeneic peripheral progenitor cells.
Bone marrow transplantation 1998;21 Suppl 3():S3-8.
1998: Schmitz N
[Therapy of highly malignant non-Hodgkin lymphoma with high-dose chemotherapy and stem cell transplantation]
Praxis 1998;87(25-26):863-8.
1998: Dreger P; von Neuhoff N; Kuse R; Sonnen R; Glass B; Uharek L; Schoch R; Löffler H; Schmitz N
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
British journal of cancer 1998;77(12):2291-7.
1998: Schmitz N; Bacigalupo A; Hasenclever D; Nagler A; Gluckman E; Clark P; Bourquelot P; Greinix H; Frickhofen N; Ringdén O; Zander A; Apperley J F; Gorin C; Borkett K; Schwab G; Goebel M; Russell N H; Gratwohl A
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(10):995-1003.
1998: Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Experimental hematology 1998;26(2):93-9.
1998: Goldman J M; Schmitz N; Niethammer D; Gratwohl A
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(1):1-7.
1997: Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
Bone marrow transplantation 1997;20(7):533-41.
1997: Paulus U; Schmitz N; Viehmann K; von Neuhoff N; Dreger P
Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
Bone marrow transplantation 1997;20(5):415-20.
1997: Suttorp M; Ritgen M; von Neuhoff N; Schoch R; Schmitz N
Blood on filter paper as a readily available source of bcr-abl rearranged mRNA.
Blood 1997;90(4):1713-5.
1997: Glass B; Uharek L; Zeis M; Dreger P; Löffler H; Steinmann J; Schmitz N
Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect.
Blood 1997;90(4):1694-700.
1997: Anderlini P; Körbling M; Dale D; Gratwohl A; Schmitz N; Stroncek D; Howe C; Leitman S; Horowitz M; Gluckman E; Rowley S; Przepiorka D; Champlin R
Allogeneic blood stem cell transplantation: considerations for donors.
Blood 1997;90(3):903-8.
1997: Dreger P; Glass B; Uharek L; Zeis M; Schmitz N
Allogenic transplantation of mobilized peripheral blood progenitor cells: towards tailored cell therapy.
International journal of hematology 1997;66(1):1-11.
1997: Schmitz N; Diehl V
Carmustine and the lungs .
Lancet 1997;349(9067):1712-3.
1997: Dreger P; von Neuhoff N; Kuse R; Sonnen R; Glass B; Uharek L; Bartels H; Löffler H; Schmitz N
Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):401-3.
1997: Dreger P; Schmitz N
The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 2():S42-5.
1997: Zeis M; Uharek L; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N
Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice.
British journal of haematology 1997;96(4):757-61.
1997: Schmitz N
[Therapy of recurrent high-grade non-Hodgkin's lymphoma]
Der Internist 1997;38(2):143-9.
1997: Suttorp M; Schmitz N
[Polymerase chain reaction]
Medizinische Klinik (Munich, Germany : 1983) 1997;92(1):37-40.
1997: Smith T J; Hillner B E; Schmitz N; Linch D C; Dreger P; Goldstone A H; Boogaerts M A; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder M H
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):5-10.
1997: Paulus U; Dreger P; Viehmann K; von Neuhoff N; Schmitz N
Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems.
Stem cells (Dayton, Ohio) 1997;15(4):297-304.
1996: Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte J P; Brinch L; Cook G; Deliliers G L; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A
Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 1996;95(4):715-23.
1996: Euler H H; Marmont A M; Bacigalupo A; Fastenrath S; Dreger P; Hoffknecht M; Zander A R; Schalke B; Hahn U; Haas R; Schmitz N
Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation.
Blood 1996;88(9):3621-5.
1996: Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N; Müller-Ruchholtz W
High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(11):1758-64.
1996: Dreger P; Glass B; Uharek L; Schmitz N
Allogeneic peripheral blood progenitor cells: current status and future directions.
Journal of hematotherapy 1996;5(4):331-7.
1996: Gassmann W; Schmitz N; Löffler H; De Witte T
Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
Seminars in hematology 1996;33(3):196-205.
1996: Russel N; Gratwohl A; Schmitz N
The place of blood stem cells in allogeneic transplantation.
British journal of haematology 1996;93(4):747-53.
1996: Hehlmann R; Heimpel H; Hossfeld D K; Hasford J; Kolb H J; Löffler H; Pralle H; Queisser W; Hochhaus A; Tichelli A; Fett W; Schmitz N; Reiter A; Griesshammer M; Pfeifer W; Bümler M; Kamp T; Tobler A; Eimermacher H; Kuse R; Berger U; Ansari H
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Bone marrow transplantation 1996;17 Suppl 3():S21-4.
1996: Suttorp M; von Neuhoff N; Tiemann M; Dreger P; Schaub J; Löffer H; Parwaresch R; Schmitz N
Precast commercial polyacrylamide gels for separation of DNA amplificates by temperature gradient gel electrophoresis: application to clonality analysis of lymphomas.
Electrophoresis 1996;17(4):672-7.
1996: Schmitz N; Gratwohl A; Goldman J M
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 1996;17(4):471-7.
1996: Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte J P; Brinch L; Cook G; Lambertenghi-Deliliers G; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Bone marrow transplantation 1996;17 Suppl 2():S40-6.
1996: Dreger P; Oberböster K; Schmitz N
PBPC grafts from healthy donors: analysis of CD34+ and CD3+ subpopulations.
Bone marrow transplantation 1996;17 Suppl 2():S22-7.
1996: Gratwohl A; Schmitz N
First international symposium on allogeneic peripheral blood precursor cell transplants.
Bone marrow transplantation 1996;17 Suppl 2():S1-3.
1996: Schlegelberger B; Zwingers T; Hohenadel K; Henne-Bruns D; Schmitz N; Haferlach T; Tirier C; Bartels H; Sonnen R; Kuse R
Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):593-9.
1996: Schmitz N; Linch D C; Dreger P; Goldstone A H; Boogaerts M A; Ferrant A; Demuynck H M; Link H; Zander A; Barge A
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
Lancet 1996;347(8998):353-7.
1995: Ringdén O; Lönnqvist B; Hägglund H; Ljungman P; Shanwell A; Lawlor E; Schmitz N
Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease.
Bone marrow transplantation 1995;16(6):856-7.
1995: Link H; Schmitz N; Gratwohl A; Goldman J
Standards for specialist units undertaking blood and marrow stem cell transplants--recommendations from the EBMT. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 1995;16(6):733-6.
1995: Dreger P; Klöss M; Petersen B; Haferlach T; Löffler H; Loeffler M; Schmitz N
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Blood 1995;86(10):3970-8.
1995: Dreger P; von Neuhoff N; Suttorp M; Löffler H; Schmitz N
Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads.
Bone marrow transplantation 1995;16(4):627-9.
1995: Schmitz N; Dreger P; Suttorp M; Rohwedder E B; Haferlach T; Löffler H; Hunter A; Russell N H
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)
Blood 1995;85(6):1666-72.
1995: Schmitz N; Dreger P; Zander A R; Ehninger G; Wandt H; Fauser A A; Kolb H J; Zumsprekel A; Martin A; Hecht T
Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Bone marrow transplantation 1995;15(2):261-6.
1995: Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
Experimental hematology 1995;23(2):147-54.
1995: Schmitz N
Allogeneic transplantation of peripheral blood progenitor cells.
Nouvelle revue française d'hématologie 1995;37(6):377-9.
1995: Hasenclever D; Schmitz N; Diehl V
Is there a rationale for high-dose chemotherapy as first line treatment of advanced Hodgkin's disease? German Hodgkin's Lymphoma Study Group (GHSG).
Leukemia & lymphoma 1995;15 Suppl 1():47-9.
1994: Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
British journal of haematology 1994;87(3):609-13.
1994: Dreger P; Suttorp M; Löffler H; Schmitz N
Influence of G-CSF on NK cell recovery after autologous BMT.
Bone marrow transplantation 1994;13(5):667-8.
1994: Pfreundschuh M G; Rueffer U; Lathan B; Schmitz N; Brosteanu O; Hasenclever D; Haas R; Kirchner H; Koch P; Kuse R
Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):580-6.
1994: Suttorp M; Rister M; Schmitz N
Interferon-alpha-2 (IFN) plus hydroxyurea for treatment of juvenile chronic myelogenous leukemia.
Medical and pediatric oncology 1994;22(5):358-9.
1994: Dreger P; Steinmann J; Drost R; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
Enrichment of G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation by negative selection.
Progress in clinical and biological research 1994;389():407-13.
1993: Dreger P; Marquardt P; Haferlach T; Jacobs S; Mülverstedt T; Eckstein V; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product.
British journal of cancer 1993;68(5):950-7.
1993: Schmitz N; Glass B; Dreger P; Haferlach T; Horst H A; Ollech-Chwoyka J; Suttorp M; Gassmann W; Löffler H
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease.
Annals of hematology 1993;66(5):251-6.
1993: Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(5):679-87.
1993: Suttorp M; Sprenger C; Dreger P; Sievers E; Claviez A; Löffler H; Schaub J; Schmitz N
Amplification of a Y-chromosomal DNA sequence by the polymerase chain reaction for documentation of residual recipient cells in small samples from bone marrow, peripheral blood and cerebrospinal fluid after bone marrow transplantation.
Electrophoresis 1993;14(3):174-8.
1993: Dreger P; Suttorp M; Haferlach T; Löffler H; Schmitz N; Schroyens W
Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation.
Blood 1993;81(5):1404-7.
1993: Dreger P; Grelle K; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
Granulocyte-colony-stimulating factor induces increased serum levels of soluble interleukin 2 receptors preceding engraftment in autologous bone marrow transplantation.
British journal of haematology 1993;83(1):7-13.
1993: Dreger P; Viehmann K; Steinmann J; Schmitz N; Suttorp M; Eckstein V; Löffler H; Müller-Ruchholtz W
CD48 monoclonal antibody K31 for bone marrow transplantation: T-depleting capacity and influence on hematopoietic progenitors.
Bone marrow transplantation 1993;12 Suppl 3():S13-7.
1992: Schmitz N; Suttorp M; Schlegelberger B; Weber-Matthiesen K; Tiemann M; Sonnen R
The role of the spleen after bone marrow transplantation for primary myelofibrosis.
British journal of haematology 1992;81(4):616-8.
1992: Löffler H; Schmitz N; Gassmann W
Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
Hematology/oncology clinics of North America 1992;6(3):619-31.
1992: Dreger P; Steinmann J; Schmitz N; Eckstein V; Löffler H; Müller-Ruchholtz W
CD48 monoclonal antibody K31 for bone marrow transplantation.
Progress in clinical and biological research 1992;377():441-7.
1991: Schmitz N; Prange E; Haferlach T; Griesser H; Sonnen R; Schlegelberger B; Claus S; Löffler H
High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD).
Bone marrow transplantation 1991;8(6):503-6.
1991: Suttorp M; Schmitz N; Prange E; Oster W; Löffler H; Schaub J; Ganser A
Remission of juvenile chronic myeloid leukemia following graft failure of an unrelated marrow transplant and autologous recovery of marrow function promoted by GM-CSF and IL-3.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(8):723-5.
1991: Gassmann W; Uharek L; Erbersdobler A; Glass B; Wottge H U; Schmitz N; Löffler H; Mueller-Ruchholtz W
High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.
British journal of haematology 1991;78(3):310-8.
1991: Schmitz N; Schlegelberger B; Oberböster K; Golchert K; Suttorp M; Löffler H
Lymphohaematopoietic chimaerism after bone marrow transplantation for chronic myeloid leukaemia: results of simultaneous cytogenetic analyses on T-cell colonies, myeloid, and erythroid progenitor cells.
British journal of haematology 1991;78(3):334-42.
1991: Horst H A; Schmitz N; Glinike C; Löffler H; Laufs R
Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin.
The New England journal of medicine 1991;325(2):132-3.
1991: Schmitz N
[Possibilities and limits of bone marrow transplantation]
Krankenpflege (Frankfurt am Main, Germany) 1991;45(1):51-4.
1991: Suttorp M; Schmitz N; Prange E; Ganser A; Löffler H; Schaub J
Successful stimulation of autologous bone marrow recovery by GM-CSF and IL-3 after an unrelated donor BMT for juvenile CML complicated by graft failure.
Bone marrow transplantation 1991;7 Suppl 2():84.
1990: Hiddemann W; Schmitz N; Pfreundschuh M; Pflüger K H; Ollech-Chwoyka J; Tirier C; Maschmeyer G; Kirchner H; Wagner T; Koch P
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.
Cancer 1990;66(5):838-43.
1990: Nölle I; Schlegelberger B; Schmitz N; Bödewadt-Radzun S; Grote W
Acute monocytic leukemia with translocation t(1;11) (p31;q23): simultaneous staining of chromosomes and cell surface antigens.
Haematology and blood transfusion 1990;33():145-9.
1989: Niethammer D; Dopfer R; Klingebiel T; Riehm H; Schellong G; Henze G; Bender-Götze C; Haas R J; Schmitz N; Friedrich W
Actual role and perspectives of BMT in children.
Bone marrow transplantation 1989;4 Suppl 4():7-11.
1989: Suttorp M; Schmitz N; Leuschner S; Appelt M; Rister M; Schaub J
Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias.
Bone marrow transplantation 1989;4 Suppl 4():144-8.
1989: Gassmann W; Schmitz N; Wottge H U; Löfler H; Müller-Ruchholtz W
[Historical survey on the development of bone marrow transplantation]
Deutsche medizinische Wochenschrift (1946) 1989;114(28-29):1124-9.
1989: Niethammer D; Dopfer R; Ehninger G; Schäfer U W; Stollmann B; Rister M; Schmitz N; Bender-Götze C; Haas R J; Kolb H
Bone marrow transplantation in childhood leukaemia--experience and strategies in the Federal Republic of Germany.
Folia haematologica (Leipzig, Germany : 1928) 1989;116(3-4):361-6.
1988: Gassmann W; Uharek L; Wottge H U; Schmitz N; Löffler H; Mueller-Ruchholtz W
Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation.
Blood 1988;72(5):1574-9.
1988: Schmitz N; Gassmann W; Rister M; Johannson W; Suttorp M; Brix F; Holthuis J J; Heit W; Hertenstein B; Schaub J
Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias.
Blood 1988;72(5):1567-73.
1987: Schmitz N; Johannson W; Schmidt G; von der Helm K; Löffler H
Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6.
Blood 1987;70(4):1099-104.
1987: Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho A D; Parwaresch R M; Schmitz N; Papendick U
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1987;1(4):337-40.
1987: Kayser W; Spiegel K; Schmitz N; Löffler H
Application of a microseparation technique allowing for extensive marker studies on small bone marrow specimens.
Journal of immunological methods 1987;97(2):245-9.
1987: Schmitz N; Gassmann W; Kayser W; Löffler H
[Autologous bone marrow transplantation in Hodgkin's disease]
Deutsche medizinische Wochenschrift (1946) 1987;112(8):314-20.
1987: Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho A D; Parwaresch R M; Schmitz N; Papendick U
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]
Onkologie 1987;10(1):5-10.
1987: Gassmann W; Schmitz N; Kayser W; Löffler H
[Ultrahigh-dosage cytostatics--their possible use in acute leukemias?]
Deutsche medizinische Wochenschrift (1946) 1987;112(2):65-72.
1987: Niethammer D; Ehninger G; Dopfer R; Ostendorf P; Waller H D; Bender-Götze C; Haas R J; Kolb H J; Wündisch G F; Schmitz N
Bone marrow transplantation in childhood leukemia in West Germany.
Haematology and blood transfusion 1987;30():217-25.
1987: Löffler H; Kayser W; Schmitz N; Thiel E; Hoelzer D; Büchner T; Urbanitz D; Spiegel K; Messerer D; Heinecke A
Morphological and cytochemical classification of adult acute leukemias in two multicenter studies in the Federal Republic of Germany.
Haematology and blood transfusion 1987;30():21-7.
1986: Gassmann W; Bikfalvi A; Schmitz N; Löffler H
[Intrathoracic involvement in Hodgkin's disease. Diagnosis--therapy--prognosis]
Praxis und Klinik der Pneumologie 1986;40(7):293-300.
1986: Schröder O; Schmitz N; Kayser W; Euler H H; Löffler H
[Elevated cyclosporin A level during simultaneous therapy with danazol]
Deutsche medizinische Wochenschrift (1946) 1986;111(15):602-3.
1986: Schmitz N; Gassmann W; Löffler H
[Clinical aspects of bone marrow transplantation]
Terapevticheskii arkhiv 1986;58(9):18-23.
1985: Kayser W; Euler H H; Schmitz N; Gassmann W; Löffler H; Asbeck F
Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report.
Blut 1985;51(6):401-4.
1985: Schmitz N; Kayser W; Gassmann W; Euler H H; Wüstemann M; Brix F; Dühmke E; Hebbinghaus D; Gremmel H; Schaub J
[Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center]
Deutsche medizinische Wochenschrift (1946) 1985;110(39):1488-93.
1985: Schmitz N; Gassmann W; Rautenberg P; Löffler H
[Experiences with cytomegalovirus hyperimmunoglobulin after bone marrow transplantation]
Immunität und Infektion 1985;13(5):224-8.
1985: Euler H H; Schmitz N; Löffler H
Plasmapheresis in paraproteinemia.
Blut 1985;50(6):321-30.
1985: Schmitz N; Gödde-Salz E; Löffler H
Cytogenetic studies on recipients of allogeneic bone marrow transplants after fractionated total body irradiation.
British journal of haematology 1985;60(2):239-44.
1985: Gassmann W; Pralle H; Haferlach T; Pandurevic S; Graubner M; Schmitz N; Löffler H
Staging systems for multiple myeloma: a comparison.
British journal of haematology 1985;59(4):703-11.
1985: Schmitz N; Maubach P A; Gödde-Salz E; Gassmann W; Löffler H
Acute eosinophilic leukemia: characterization by cytochemistry, chromosomal analysis, and in vitro colony formation.
Klinische Wochenschrift 1985;63(3):133-7.
1985: Gassmann W; Schmitz N; Löffler H
[Results of high-dose cytarabine therapy. A review]
Onkologie 1985;8(1):8-15.
1984: Gassmann W; Schmitz N; Kayser W; Löffler H
Hodgkin's disease.
Cancer treatment reviews 1984;11(4):311-4.
1984: Gassmann W; Haferlach T; Engelhardt K H; Rabenhorst G; Junge W; Schmitz N; Kayser W; Euler H H; Löffler H
[IgD plasmacytoma]
Deutsche medizinische Wochenschrift (1946) 1984;109(46):1775-9.
1984: Gassmann W; Haferlach T; Schmitz N; Kayser W; Euler H H; Drews J; Löffler H
[Analysis of prognostic factors in plasmacytoma]
Klinische Wochenschrift 1984;62(19):896-905.
1984: Schmitz N; Gassmann W; Kayser W; Löffler H
[Chronic myelocytic leukemia: indication for bone marrow transplantation]
Deutsche medizinische Wochenschrift (1946) 1984;109(27):1074-7.
1984: Schmitz N; Gödde-Salz E; Gassmann W; Löffler H
Acute myelomonocytic leukemia with involvement of eosinophils and inversion of chromosome 16.
Blut 1984;48(5):263-7.
1983: Gassmann W; Haferlach T; Schmitz N; Kayser W; Löffler H
[Problems of intravenous urography in patients with plasmocytoma]
Schweizerische medizinische Wochenschrift 1983;113(8):301-4.
1983: Löffler H; Gassmann W; Schmitz N
[Clinical course of acute leukemia]
Verhandlungen der Deutschen Gesellschaft für Pathologie 1983;67():143-8.
1982: Gassmann W; Schmitz N; Löffler H
[Virus etiology of Hodgkin's disease]
Deutsche medizinische Wochenschrift (1946) 1982;107(31-32):1171-2.
1982: Gassmann W; Schmitz N; Löffler H
[10 years of DeVita protocol]
Deutsche medizinische Wochenschrift (1946) 1982;107(27):1043-4.
1982: Gassmann W; Schmitz N; Löffler H
[The practice of chemotherapy with the DeVita protocol]
Deutsche medizinische Wochenschrift (1946) 1982;107(27):1063-9.
1982: Gassmann W; Schmitz N; Breidenbach M; Haas R; Barth G; Pralle H; Löffler H
[Results of radiotherapy in case of Hodgkin's disease after primary failure of chemotherapy and recurrence after chemotherapy ]
Strahlentherapie 1982;158(6):336-41.
1982: Gassmann W; Perenyi L; Schmitz N; Kayser W; Pralle H; Löffler H
Prognostic factors in COPP-treated patients with Hodgkin's disease.
Blut 1982;44(6):339-48.
1982: Schmitz N; Kayser W; Gassmann W; Hühn A; Krüger G; Sachs V; Löffler H
Two cases of graft-versus-host disease following transfusion of nonirradiated blood products.
Blut 1982;44(2):83-8.
1982: Schmitz N; Gassmann W; Löffler H
[Substitution with immunoglobulins in leukemia]
Beiträge zu Infusionstherapie und klinische Ernährung 1982;9():25-33.
1981: Löffler H; Gassmann W; Schmitz N; Pralle H
[Current status of chemotherapy for Hodgkin's disease]
Die Medizinische Welt 1981;32(25):1010-6.
1981: Gassmann W; Perenyi L; Pralle H; Graubner M; Schmitz N; Löffler H
[Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)]
Klinische Wochenschrift 1981;59(6):267-73.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Norbert Schmitz

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Norbert Schmitz (preview)

All Publications